title: Screening of platelet concentrates for bacterial contamination: spectrum of bacteria detected, proportion of transfused units, and clinical follow-up.
abstract: Screening of platelet concentrates (PCs) for bacterial contamination with cultivation methods is carried out as a routine procedure in some countries. The aim is to prevent the transfusion of contaminated PCs. The German Evaluation of Regular Monitoring Study Group conducted a prospective multicenter study on 52,243 PCs to investigate the prevalence of bacteria (BacT/ALERT, bioMerieux). This study describes the detected bacterial spectrum, the proportion of PCs with a positive test result that had been transfused, and the results of the clinical follow-up. One hundred thirteen (67%) of 169 potentially or confirmed positive units had already been transfused at the time of the first positive signal. The transfusion of units contaminated by Staphylococcus aureus, Serratia marcescens, and 73% of the units contaminated with Staphylococcus epidermidis, Staphylococcus capitis, or Staphylococcus saccharolyticus was prevented. In contrast, 85% of units with Propionibacterium acnes were transfused. A clonal relationship of the isolates from the pooled PCs and from the associated red blood cell concentrates was found in all investigated cases. The follow-up revealed six febrile reactions to culture-positive PCs not classified as transfusion reaction (TRs) by treating physicians. This demonstrates the importance of hemovigilance. Serious septic reactions due to Klebsiella pneumoniae in two units of one apheresis PC that had tested false-negative were reported; one had a fatal outcome. Culture systems reduce the risk of transfusion of contaminated PCs but cannot guarantee sterility. Physicians must be aware of bacterial contamination of PCs as a potential cause of TRs and must report all adverse events.
authors.affiliation: German Red Cross Blood Service West, Muenster, Germany. G.Walther-Wenke@bsdwest.de
authors.forename: Gabriele
authors.initials: G
authors.lastname: Walther-Wenke
authors.forename: Hubert
authors.initials: H
authors.lastname: Schrezenmeier
authors.forename: Robert
authors.initials: R
authors.lastname: Deitenbeck
authors.forename: Gabriele
authors.initials: G
authors.lastname: Geis
authors.forename: Jürgen
authors.initials: J
authors.lastname: Burkhart
authors.forename: Britta
authors.initials: B
authors.lastname: Höchsmann
authors.forename: Walid
authors.initials: W
authors.lastname: Sireis
authors.forename: Michael
authors.initials: M
authors.lastname: Schmidt
authors.forename: Erhard
authors.initials: E
authors.lastname: Seifried
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Gebauer
authors.forename: Ute-Maja
authors.initials: UM
authors.lastname: Liebscher
authors.forename: Franz
authors.initials: F
authors.lastname: Weinauer
authors.forename: Thomas H
authors.initials: TH
authors.lastname: Müller
mesh_terms: D001431:Bacteriological Techniques / Q000379:methods / Q000592:standards; D001792:Blood Platelets / Q000382:microbiology*; D005500:Follow-Up Studies; D006801:Humans; D008403:Mass Screening / Q000379:methods* / Q000592:standards*; D017713:Platelet Transfusion / Q000592:standards*